Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.

Chicago Board Options ExchangeEquity
At close
$36.0359
$0.00 · 0.00%
Sep 15, 9:46 AM ET
Regular session · ET · Market data may be delayed.
XBIX seeks to deliver 200% of the daily performance of SPDR S&P Biotech ETF (Ticker: XBI), a passively managed ETF with a targeted exposure to US biotechnology stocks. Rather than holding XBI directly, the fund primarily uses derivatives such as swap agreements and options to create leveraged exposure. The portfolio is rebalanced at the end of each trading day to maintain its targeted leverage level, meaning returns over periods longer than a single day can differ significantly from two times the cumulative return of XBI due to compounding effects. The fund may also obtain leveraged exposure through exchange-traded equity futures contracts and exchange-traded options contracts, including standardized call and put options. Collateral supporting these derivative positions may be invested in money market instruments, repurchase agreements, or short-term US government securities.
Fund assets
540.25K USD
Expense ratio
0.45%
NAV
$36.02
Average volume
1.09K
Volume
131
Day range
$36.0359 – $38.53
52-week range
$25.13 – $42.22
Previous close
$36.0359
Price change
1 day
0.00%
1 month
-1.51%
3 months
+28.15%
Year to date
+39.57%
1 year
+39.57%
3 years
+39.57%
5 years
+39.57%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Sep 15, 2026.
Latest coverage
No ETF news is currently available.
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.